AstraZeneca PLC ADR outperforms competitors on strong trading day

This article was originally published on this site

© Terrence Horan


The AstraZeneca PLC ADR AZN rose 1.33% to $50.86 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.03% to 13,201.98 and the Dow Jones Industrial Average DJIA rising 0.18% to 31,097.97. AstraZeneca PLC ADR closed $14.08 below its 52-week high ($64.94), which the company reached on July 20th.

Video: Small cap stocks poised for growth: fund manager (Reuters)

Small cap stocks poised for growth: fund manager
What to watch next

The ADR demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. ABBV rose 0.52% to $107.27, Amgen Inc. AMGN rose 1.91% to $238.49, and Gilead Sciences Inc. GILD rose 0.83% to $63.04. Trading volume (11.0 M) eclipsed its 50-day average volume of 10.2 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading